NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-221-1993-3-DE-16 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders DE EP 94930694.8 Abandoned
NCI E-221-1993-3-FR-17 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders FR EP 94930694.8 Abandoned
NCI E-221-1993-3-ES-21 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders ES EP 94930694.8 Abandoned
NCI E-221-1993-3-PT-20 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders PT EP 94930694.8 Abandoned
NCI E-221-1993-3-IE-18 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders IE EP 94930694.8 Abandoned
NCI E-221-1993-3-IT-19 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders IT EP 94930694.8 Abandoned
NCI E-221-1993-3-BE-14 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders BE EP 94930694.8 Abandoned
NCI E-221-1993-3-AT-13 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders AT EP 94930694.8 Abandoned
NCI E-221-1993-3-CH-15 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders CH EP 94930694.8 Abandoned
NCI E-221-1993-3-GB-22 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders GB EP 94930694.8 Abandoned
NCI E-221-1993-3-EP-02 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders EP National Stage 94930694.8 Abandoned
NCI E-221-1993-3-JP-10 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING PATHOLOGIES INCLUDING CANCER JP National Stage 7-511977 Abandoned
NCI E-221-1993-3-PH-11 COMPOSITION AND METHODS FOR TREATING AND PREVENTING PATHOLOGIES INCLUDING CANCER PH National Stage 94930694.8 Abandoned
NCI E-221-1993-3-IL-04 Compositions & Methods for Treating Pathologies Including Cancer IL National Stage 94930694.8 Abandoned
NCI E-221-1993-3-AU-08 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders AU National Stage 79737/94 Abandoned
NCI E-214-1994-0-US-01 ENZYMATIC DEGRADING SUBTRACTION HYBRIDIZATION US ORD 08/322,075 5525471 Expired PDF
NCI E-221-1993-3-ZA-07 Composition and Methods for Treating Pathologies Including Cancer ZA National Stage 94/7964 Abandoned
NCI E-221-1993-3-PCT-01 PHENYLACETATE AND DERIVATIVES ALONE OR IN COMBINATION WITH OTHER COMPOUNDS AGAINST NEOPLASTIC CONDITIONS AND OTHER DISORDERS PCT PCT COMB PCT/US1994/011492 Expired
NCI E-221-1993-3-KR-05 Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders KR National Stage 96701885 Abandoned
NCI E-221-1993-3-JP-12 Compositions and Methods for Treating and Preventing Pathologies Including Cancer JP DIV 2002-302292 Abandoned
NCI E-221-1993-3-JP-03 Compositions and Methods for Treating and Preventing Pathologies Including Cancer JP National Stage 2001-69516 Abandoned
NIEHS E-016-1993-0-US-01 FLUORESCENT AND NMR SENSITIVE INTRACELLULAR PH INDICATORS US ORD 08/320,986 5639906 Expired PDF
NCI E-222-1993-0-AU-04 USE OF NITRIC OXIDE RELEASING COMPOUNDS AS HYPOXIC CELL RADIATION SENSITIZERS AU National Stage 79673/94 Abandoned
NCI E-222-1993-1-US-01 USE OF NITRIC OXIDE RELEASING COMPOUNDS AS HYPOXIC CELL RADIATION SENSITIZERS US CIP 08/319,888 5650442 Abandoned PDF
NCI E-222-1993-0-PCT-02 USE OF NITRIC OXIDE-RELEASING COMPOUNDS AS HYPOXIC CELL RADIATION SENSITIZERS PCT PCT PCT/US1994/011306 Expired
NCI E-222-1993-0-EP-05 USE OF NITRIC OXIDE RELEASING COMPOUNDS AS HYPOXIC CELL RADIATION SENSITIZERS EP National Stage 94930608.8 Abandoned
NCI E-124-1992-2-US-01 ENCAPSULATED AND NON-ENCAPSULATED NITRIC OXIDE GENERATORS USED AS ANTIMICROBIAL AGENTS US CIP 08/319,744 Abandoned
NCI E-245-1994-0-US-01 CHIMERIC PAPILLOMA VIRUS-LIKE PARTICLES US CIP 08/319,467 5618536 Expired PDF
NIDDK E-069-1988-0-US-02 CARBAMATES RELATED TO (-)-PHYSOSTIGMINE AS CHOLINERGIC AGENTS US CON 08/319,245 Abandoned
NIEHS E-237-1994-4-US-01 ISOLATION OF BRCA1 GENE AND ITS INVOLVEMENT IN SPORADIC BREAST AND OVARIAN CANCER US ORD 08/319,511 Abandoned
NCI E-040-1992-2-PCT-02 TREATMENT OF TUMORS BY GENETIC TRANSFORMATION OF TUMOR CELLS WITH GENES ENCODING NEGATIVE SELECTIVE MARKERS AND CYTOKINES PCT PCT PCT/US1994/011251 Expired
NCI E-040-1992-2-JP-06 TREATMENT OF TUMORS BY GENETIC TRANSFORMATION OF TUMOR CELLS WITH GENES ENCODING NEGATIVE SELECTIVE MARKERS AND CYTOKINES JP National Stage 1995-510988 Abandoned
NCI E-040-1992-2-DE-05 TREATMENT OF TUMORS BY GENETIC TRANSFORMATION OF TUMOR CELLS WITH GENES ENCODING NEGATIVE SELECTIVE MARKERS AND CYTOKINES DE National Stage 94930031.3 Abandoned
NCI E-040-1992-2-CA-04 TREATMENT OF TUMORS BY GENETIC TRANSFORMATION OF TUMOR CELLS WITH GENES ENCODING NEGATIVE SELECTIVE MARKERS AND CYTOKINES CA National Stage 2173495 Abandoned
NIAID E-141-1992-1-US-01 RECOMBINANT PROTEINS OF A PAKISTANI STRAIN OF HEPATITIS E AND THEIR USE IN DIAGNOSTIC METHODS AND VACCINES US CIP 08/316,765 6706873 Abandoned PDF
NCI E-079-1995-0-US-01 The IRS Family of Genes US ORD 08/317,310 5858701 Expired PDF
NCI E-260-1994-0-US-01 ENHANCED IMMUNE RESPONSE TO AN ANTIGEN BY A COMPOSITION OF A RECOMBINANT VIRUS EXPRESSING THE ANTIGEN WITH A RECOMBINANT VIRUS ...0 US ORD 08/317,268 Abandoned
NCI E-259-1994-0-US-01 ENHANCED IMMUNE RESPONSE BY INTRODUCTION OF CYTOKINE GENE AND/OR COSTIMULATORY MOLECULE B7 GENE IN A RECOMBINANT VIRUS EXPRESSING US ORD 08/317,402 Abandoned
NINDS E-250-1993-0-PCT-02 Gene Therapy of the Nervous System PCT PCT PCT/US1994/010977 Expired
NINDS E-250-1993-0-JP-05 GENE THERAPY OF THE NERVOUS SYSTEM (application as filed) JP National Stage 1995-510881 Abandoned
NINDS E-250-1993-0-EP-04 GENE THERAPY OF THE NERVOUS SYSTEM (application as filed) EP National Stage 94930498.4 Abandoned
NINDS E-250-1993-0-CA-03 GENE THERAPY OF THE NERVOUS SYSTEM (application as filed) CA National Stage 2171109 Abandoned
NCI E-317-1984-15-US-06 Methods for the preparation of hybridomas producing lymphadenopathy-associated virus (LAV) GP110-specific monoclonal antibodies and methods for the purification of GP110 employing said monoclonal antibodies US CON 08/313,572 5610035 Expired PDF
NHLBI E-037-1993-0-US-03 MAMMALIAN GUANINE NUCLEOTIDE BINDING PROTEIN WITH AN ADP-RYBOSYLATION FACTOR DOMAIN US DIV 08/312,648 5514600 Expired PDF
NINDS E-092-1993-1-US-01 CELL TEST FOR ALZHEIMER'S DISEASE: PROTEIN ANALYSIS US CIP 08/312,202 5976816 Expired PDF
NCI E-231-1993-2-CA-16 CONFORMATIONALLY LOCKED NUCLEOSIDE ANALOGUES CA National Stage 2172534 Expired
NCI E-231-1993-2-JP-17 CONFORMATIONALLY LOCKED NUCLEOSIDE ANALOGUES JP National Stage 1995-509961 Expired
NCI E-231-1993-2-SG-18 CONFORMATIONALLY LOCKED NUCLEOSIDE ANALOGUES SG National Stage 9607728-4 Expired
NCI E-231-1993-2-ES-12 CONFORMATIONALLY LOCKED NUCLEOSIDE ANALOGUES ES EP 94929321.1 Expired
NCI E-231-1993-2-PT-09 CONFORMATIONALLY LOCKED NUCLEOSIDE ANALOGUES PT EP 94929321.1 Expired